The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Immunomodulators Market Research Report 2024

Global Immunomodulators Market Research Report 2024

Publishing Date : Jul, 2023

License Type :
 

Report Code : 1415249

No of Pages : 93

Ask Your Query

Synopsis

Immunomodulators are referred to as the medications that are used for the regulation or for normalizing the immune system.

Global Immunomodulators market is projected to reach US$ 169150 million in 2029, increasing from US$ 136630 million in 2022, with the CAGR of 3.1% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Immunomodulators market research.

The global market for immunomodualtors is expected to grow exponentially over the forecast period owing to the rising cases of chronic diseases such as multiple sclerosis, allergic conditions, cancer, and asthma.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Immunomodulators market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company (Partial List):

  •     Roche
  •     Amgen Inc.
  •     Abbott
  •     Johnson & Johnson
  •     Novartis AG
  •     Eli Lilly and Company
  •     Bristol-Myers Squibb Company
  •     Merck & Co. Inc.
  •     Biogen

Segment by Type

  •     Immunosuppressant
  •     Immunostimulants

Segment by Application

  •     Oncology
  •     Respiratory
  •     HIV
  •     Others

Consumption by Region

  •  North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

The Immunomodulators report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

 

1.1 Product Overview and Scope of Immunomodulators
    1.2 Immunomodulators Segment by Type
        1.2.1 Global Immunomodulators Market Value Comparison by Type (2023-2029)
        1.2.2 Immunosuppressant
        1.2.3 Immunostimulants
    1.3 Immunomodulators Segment by Application
        1.3.1 Global Immunomodulators Market Value by Application: (2023-2029)
        1.3.2 Oncology
        1.3.3 Respiratory
        1.3.4 HIV
        1.3.5 Others
    1.4 Global Immunomodulators Market Size Estimates and Forecasts
        1.4.1 Global Immunomodulators Revenue 2018-2029
        1.4.2 Global Immunomodulators Sales 2018-2029
        1.4.3 Global Immunomodulators Market Average Price (2018-2029)
    1.5 Assumptions and Limitations

 2 Immunomodulators Market Competition by Manufacturers
    2.1 Global Immunomodulators Sales Market Share by Manufacturers (2018-2023)
    2.2 Global Immunomodulators Revenue Market Share by Manufacturers (2018-2023)
    2.3 Global Immunomodulators Average Price by Manufacturers (2018-2023)
    2.4 Global Immunomodulators Industry Ranking 2021 VS 2022 VS 2023
    2.5 Global Key Manufacturers of Immunomodulators, Manufacturing Sites & Headquarters
    2.6 Global Key Manufacturers of Immunomodulators, Product Type & Application
    2.7 Immunomodulators Market Competitive Situation and Trends
        2.7.1 Immunomodulators Market Concentration Rate
        2.7.2 The Global Top 5 and Top 10 Largest Immunomodulators Players Market Share by Revenue
        2.7.3 Global Immunomodulators Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

 3 Immunomodulators Retrospective Market Scenario by Region
    3.1 Global Immunomodulators Market Size by Region: 2018 Versus 2022 Versus 2029
    3.2 Global Immunomodulators Global Immunomodulators Sales by Region: 2018-2029
        3.2.1 Global Immunomodulators Sales by Region: 2018-2023
        3.2.2 Global Immunomodulators Sales by Region: 2024-2029
    3.3 Global Immunomodulators Global Immunomodulators Revenue by Region: 2018-2029
        3.3.1 Global Immunomodulators Revenue by Region: 2018-2023
        3.3.2 Global Immunomodulators Revenue by Region: 2024-2029
    3.4 North America Immunomodulators Market Facts & Figures by Country
        3.4.1 North America Immunomodulators Market Size by Country: 2018 VS 2022 VS 2029
        3.4.2 North America Immunomodulators Sales by Country (2018-2029)
        3.4.3 North America Immunomodulators Revenue by Country (2018-2029)
        3.4.4 U.S.
        3.4.5 Canada
    3.5 Europe Immunomodulators Market Facts & Figures by Country
        3.5.1 Europe Immunomodulators Market Size by Country: 2018 VS 2022 VS 2029
        3.5.2 Europe Immunomodulators Sales by Country (2018-2029)
        3.5.3 Europe Immunomodulators Revenue by Country (2018-2029)
        3.5.4 Germany
        3.5.5 France
        3.5.6 U.K.
        3.5.7 Italy
        3.5.8 Russia
    3.6 Asia Pacific Immunomodulators Market Facts & Figures by Country
        3.6.1 Asia Pacific Immunomodulators Market Size by Country: 2018 VS 2022 VS 2029
        3.6.2 Asia Pacific Immunomodulators Sales by Country (2018-2029)
        3.6.3 Asia Pacific Immunomodulators Revenue by Country (2018-2029)
        3.6.4 China
        3.6.5 Japan
        3.6.6 South Korea
        3.6.7 India
        3.6.8 Australia
        3.6.9 Taiwan
        3.6.10 Indonesia
        3.6.11 Thailand
        3.6.12 Malaysia
        3.6.13 Philippines
    3.7 Latin America Immunomodulators Market Facts & Figures by Country
        3.7.1 Latin America Immunomodulators Market Size by Country: 2018 VS 2022 VS 2029
        3.7.2 Latin America Immunomodulators Sales by Country (2018-2029)
        3.7.3 Latin America Immunomodulators Revenue by Country (2018-2029)
        3.7.4 Mexico
        3.7.5 Brazil
        3.7.6 Argentina
    3.8 Middle East and Africa Immunomodulators Market Facts & Figures by Country
        3.8.1 Middle East and Africa Immunomodulators Market Size by Country: 2018 VS 2022 VS 2029
        3.8.2 Middle East and Africa Immunomodulators Sales by Country (2018-2029)
        3.8.3 Middle East and Africa Immunomodulators Revenue by Country (2018-2029)
        3.8.4 Turkey
        3.8.5 Saudi Arabia
        3.8.6 U.A.E

 4 Segment by Type
    4.1 Global Immunomodulators Sales by Type (2018-2029)
        4.1.1 Global Immunomodulators Sales by Type (2018-2023)
        4.1.2 Global Immunomodulators Sales by Type (2024-2029)
        4.1.3 Global Immunomodulators Sales Market Share by Type (2018-2029)
    4.2 Global Immunomodulators Revenue by Type (2018-2029)
        4.2.1 Global Immunomodulators Revenue by Type (2018-2023)
        4.2.2 Global Immunomodulators Revenue by Type (2024-2029)
        4.2.3 Global Immunomodulators Revenue Market Share by Type (2018-2029)
    4.3 Global Immunomodulators Price by Type (2018-2029)

 5 Segment by Application
    5.1 Global Immunomodulators Sales by Application (2018-2029)
        5.1.1 Global Immunomodulators Sales by Application (2018-2023)
        5.1.2 Global Immunomodulators Sales by Application (2024-2029)
        5.1.3 Global Immunomodulators Sales Market Share by Application (2018-2029)
    5.2 Global Immunomodulators Revenue by Application (2018-2029)
        5.2.1 Global Immunomodulators Revenue by Application (2018-2023)
        5.2.2 Global Immunomodulators Revenue by Application (2024-2029)
        5.2.3 Global Immunomodulators Revenue Market Share by Application (2018-2029)
    5.3 Global Immunomodulators Price by Application (2018-2029)

 6 Key Companies Profiled
    6.1 Roche
        6.1.1 Roche Corporation Information
        6.1.2 Roche Description and Business Overview
        6.1.3 Roche Immunomodulators Sales, Revenue and Gross Margin (2018-2023)
        6.1.4 Roche Immunomodulators Product Portfolio
        6.1.5 Roche Recent Developments/Updates
    6.2 Amgen Inc.
        6.2.1 Amgen Inc. Corporation Information
        6.2.2 Amgen Inc. Description and Business Overview
        6.2.3 Amgen Inc. Immunomodulators Sales, Revenue and Gross Margin (2018-2023)
        6.2.4 Amgen Inc. Immunomodulators Product Portfolio
        6.2.5 Amgen Inc. Recent Developments/Updates
    6.3 Abbott
        6.3.1 Abbott Corporation Information
        6.3.2 Abbott Description and Business Overview
        6.3.3 Abbott Immunomodulators Sales, Revenue and Gross Margin (2018-2023)
        6.3.4 Abbott Immunomodulators Product Portfolio
        6.3.5 Abbott Recent Developments/Updates
    6.4 Johnson & Johnson
        6.4.1 Johnson & Johnson Corporation Information
        6.4.2 Johnson & Johnson Description and Business Overview
        6.4.3 Johnson & Johnson Immunomodulators Sales, Revenue and Gross Margin (2018-2023)
        6.4.4 Johnson & Johnson Immunomodulators Product Portfolio
        6.4.5 Johnson & Johnson Recent Developments/Updates
    6.5 Novartis AG
        6.5.1 Novartis AG Corporation Information
        6.5.2 Novartis AG Description and Business Overview
        6.5.3 Novartis AG Immunomodulators Sales, Revenue and Gross Margin (2018-2023)
        6.5.4 Novartis AG Immunomodulators Product Portfolio
        6.5.5 Novartis AG Recent Developments/Updates
    6.6 Eli Lilly and Company
        6.6.1 Eli Lilly and Company Corporation Information
        6.6.2 Eli Lilly and Company Description and Business Overview
        6.6.3 Eli Lilly and Company Immunomodulators Sales, Revenue and Gross Margin (2018-2023)
        6.6.4 Eli Lilly and Company Immunomodulators Product Portfolio
        6.6.5 Eli Lilly and Company Recent Developments/Updates
    6.7 Bristol-Myers Squibb Company
        6.6.1 Bristol-Myers Squibb Company Corporation Information
        6.6.2 Bristol-Myers Squibb Company Description and Business Overview
        6.6.3 Bristol-Myers Squibb Company Immunomodulators Sales, Revenue and Gross Margin (2018-2023)
        6.4.4 Bristol-Myers Squibb Company Immunomodulators Product Portfolio
        6.7.5 Bristol-Myers Squibb Company Recent Developments/Updates
    6.8 Merck & Co. Inc.
        6.8.1 Merck & Co. Inc. Corporation Information
        6.8.2 Merck & Co. Inc. Description and Business Overview
        6.8.3 Merck & Co. Inc. Immunomodulators Sales, Revenue and Gross Margin (2018-2023)
        6.8.4 Merck & Co. Inc. Immunomodulators Product Portfolio
        6.8.5 Merck & Co. Inc. Recent Developments/Updates
    6.9 Biogen
        6.9.1 Biogen Corporation Information
        6.9.2 Biogen Description and Business Overview
        6.9.3 Biogen Immunomodulators Sales, Revenue and Gross Margin (2018-2023)
        6.9.4 Biogen Immunomodulators Product Portfolio
        6.9.5 Biogen Recent Developments/Updates

 7 Industry Chain and Sales Channels Analysis
    7.1 Immunomodulators Industry Chain Analysis
    7.2 Immunomodulators Key Raw Materials
        7.2.1 Key Raw Materials
        7.2.2 Raw Materials Key Suppliers
    7.3 Immunomodulators Production Mode & Process
    7.4 Immunomodulators Sales and Marketing
        7.4.1 Immunomodulators Sales Channels
        7.4.2 Immunomodulators Distributors
    7.5 Immunomodulators Customers

 8 Immunomodulators Market Dynamics
    8.1 Immunomodulators Industry Trends
    8.2 Immunomodulators Market Drivers
    8.3 Immunomodulators Market Challenges
    8.4 Immunomodulators Market Restraints

 9 Research Finding and Conclusion

 10 Methodology and Data Source
    10.1 Methodology/Research Approach
        10.1.1 Research Programs/Design
        10.1.2 Market Size Estimation
        10.1.3 Market Breakdown and Data Triangulation
    10.2 Data Source
        10.2.1 Secondary Sources
        10.2.2 Primary Sources
    10.3 Author List
    10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock